
March 11 (Reuters) - CRISPR Therapeutics AG CRSP.BN:
CRISPR THERAPEUTICS PRICES UPSIZED CONVERTIBLE SENIOR NOTES OFFERING
CRISPR THERAPEUTICS AG - PRICES $550 MILLION CONVERTIBLE SENIOR NOTES DUE 2031
CRISPR THERAPEUTICS AG - GRANTS OPTION TO PURCHASE UP TO $50 MILLION ADDITIONAL NOTES